1. Home
  2. Labeler Index
  3. Seton Pharmaceuticals
  4. 13925-540
  5. Product Images: Memantine Hydrochloride

Product Images Memantine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Memantine Hydrochloride NDC 13925-540 by Seton Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 Memantine - Figure 1 Memantine

Figure 1 Memantine - Figure 1 Memantine

The text describes a chart showing the mean change from baseline in ADCS-ADL score, indicating clinical improvement or decline, with SEM data. Results are shown for both a placebo and memantine treatment group over a two-week treatment period.*

Figure 2 Memantine - Figure 2 Memantine

Figure 2 Memantine - Figure 2 Memantine

Figure 3 Memantine - Figure 3 Memantine

Figure 3 Memantine - Figure 3 Memantine

Figure 4 Memantine - Figure 4 Memantine

Figure 4 Memantine - Figure 4 Memantine

Figure 5 Memantine - Figure 5 Memantine

Figure 5 Memantine - Figure 5 Memantine

Figure 6 Memantine - Figure 6 Memantine

Figure 6 Memantine - Figure 6 Memantine

Figure 7 Memantine - Figure 7 Memantine

Figure 7 Memantine - Figure 7 Memantine

Figure 8 Memantine - Figure 8 Memantine

Figure 8 Memantine - Figure 8 Memantine

Memantine Instructions - Instructions

Memantine Instructions - Instructions

Instructions for using a syringe and plastic bottle adapter to administer Memantine Hydrochloride Oral Solution. The guidelines include removing the adapter from its protective plastic bag and inserting it properly into the neck of the bottle, filling the syringe with the prescribed dosage, administering the solution to the patient orally, and ensuring proper cleaning and storage of the syringe and adapter. Detailed figures are provided to assist with the steps.*

Memantine Bottle - Memantine bottle

Memantine Bottle - Memantine bottle

Table 1 - Table 1

Table 1 - Table 1

This appears to be a chart comparing the percentage of adverse reactions between a placebo group and a group using memantine hydrochloride. The adverse reactions listed include fatigue, pain, hypertension, dizziness, headache, constipation, vomiting, back pain, confusion, somnolence, hallucination, coughing, and dyspnea. The percentages vary between the two groups, with some reactions being higher in the group using memantine hydrochloride and some being higher in the placebo group.*

dosing-titration-schedule - dosing titration schedule

dosing-titration-schedule - dosing titration schedule

This appears to be a medication dosing chart displaying the total daily dose as well as the strength per dose in milligrams. The dosing increases over the course of three weeks with specific amounts listed for the first and second daily doses.*

Label - label

Label - label

This is a description of a medication, Memantine Hydrochloride Oral Solution, available only with a prescription, containing 2 mg of memantine hydrochloride in each mL of solution. The bottle contains 12 fl oz (360 mL) of solution and has a tamper-evident seal. It should be kept out of reach of children and stored at a temperature between 15-30°C (59-86°F). The dosage information can be found in the package insert. The medication is manufactured by Wedly Pharmaceuticals Ltd. in India and Seton Pharmaceuticals in Wall, NJ, USA. The lot number and expiration date are not available.*

memantine-structure - memantine structure

memantine-structure - memantine structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.